Key facts
- This page summarizes Michael W. Triplett's Form 4 filing for Cigna Group (CI).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Aug 2024, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2024.
Footnote F2
Represents the weighted average price of the shares sold. The prices actually received ranged from $329.045 to $329.769 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Footnote F3
Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
Footnote F4
This option was granted on February 28, 2017. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.